This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

HENRY E. MICHELSON, M.D.; John R. Haserick, M.D.

Arch Derm Syphilol. 1948;58(6):680-695.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

VITAMIN D therapy has been used in cutaneous tuberculosis by a large number of clinicians in many countries since the first reports of Charpy and Dowling extolled the value of calciferol (vitamin D₂) in the treatment of lupus vulgaris. That the method has real value is proved beyond a doubt, but there are still some unanswered questions about the action and use of this potent vitamin; therefore, a review of our experience and of that of others up to the present time seems in order.

In using calciferol in the treatment of cutaneous tuberculosis at the University of Minnesota Hospitals, the French and English methods of administration have been combined. We prefer Dowling and Thomas' adjustment of daily doses to each patient. Our rule has been to give, orally, 1,000 units per kilogram of body weight per day to the bedridden patient and up to 2,000 units per kilogram . . . [Full Text PDF of this Article]

Author Affiliations
MINNEAPOLIS

From the Division of Dermatology, University of Minnesota, Henry E. Michelson, Director.

Footnotes
Read at the Sixty-Eighth Annual Meeting of the American Dermatological Association, Inc., San Diego, Calif., April 27, 1948.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?